Is TB-500 Legal in Ohio? How to Access It Through a Licensed Provider

HealthRX.com

TB-500 is not approved, and compounding it is not covered

Print or save as PDF

See the public record for TB-500

  • FDA approval / None; no approved product in the US or the 10 other countries FDA checked [1]
  • FDA bulks list / Not on it; FDA staff recommended against adding it [1][2]
  • Advisory committee / Voted to add it July 23, 2026; advice only [5][3]
  • HHS draft policy / October 2026; enforcement discretion for TB-500 acetate injection under conditions [3][4]
  • Sport / WADA prohibits thymosin beta-4 and its derivatives, naming TB-500 [6]

Is TB-500 an approved drug?

No. FDA's July 2026 review found no USP or National Formulary monograph for it, no FDA-approved drug containing it, and no approved product in Canada, Australia, the UK, several EU countries, or authorized by the European Medicines Agency [1]. TB-500 itself is a synthetic 7-amino-acid, N-acetylated fragment (residues 17 to 23) of the 43-amino-acid protein thymosin beta-4, not the full-length protein [1]. The review found no article in which TB-500 was given to a human [1].

Can a state-licensed pharmacy compound it?

Under the standard pathway, a state-licensed pharmacy may compound with a bulk substance only if it complies with a USP or NF monograph, is a component of an FDA-approved drug, or appears on FDA's bulks list [2]. TB-500 meets none of those and appears in none of the three interim categories on FDA's lists for state-licensed pharmacies or outsourcing facilities [7][8][2].

FDA staff recommended against adding it in July 2026. FDA's Pharmacy Compounding Advisory Committee voted in favor on July 23, 2026, but that vote is advice only and TB-500 is not on the list [1][5][3]. Its fragment sits in the nominated-but-withdrawn table on FDA's safety-risk page, and removal from category 2 was not a finding that it is safe [9].

What people on Reddit report

Reddit commenters discussing a committee vote on adding six peptides to the compounding list. They argue over whether pharmacies can legally compound these peptides now, and whether clinic arrangements are legitimate.

Rockinvestor · NTNPerformance

So any pharmacy that would be compounding them right now would be doing so at a huge risk to lose their license or may not actually be legit pharmacies.

A pharmacy owner says the peptides under review are not yet allowed on the compounding list, so pharmacies making them now face license risk.

Read the source discussion

strange_waters · NTNPerformance

I go to a wellness clinic that specializes in peptides and the doctor actually prescribes them to be compounded in a verified 503a Pharmacy.

A patient reports that their clinic's doctor prescribes these peptides for compounding at a pharmacy and asks whether that arrangement is legitimate.

Read the source discussion

Questions worth asking

Choose the questions you want to keep

What does the October 2026 HHS draft do?

The draft names TB-500 among six peptides and covers TB-500 acetate given by subcutaneous or intramuscular injection [4]. HHS says it 'does not intend to take enforcement action' against a state-licensed pharmacy, federal facility or licensed physician that meets the draft's conditions, which include a single active ingredient, a patient-specific prescription, and an FDA-registered manufacturer with a certificate of analysis [3][4]. The notice says the policy 'does not establish any rights for any person and is not binding on HHS or the public' [3].

What Ohio law adds

The Ohio Board of Pharmacy administers and enforces Ohio's pharmacy laws and the legal distribution of drugs [10]. The federal compounding limits and the conditional HHS draft described above also apply [2][3][4]. Ohio law allows the State Medical Board to discipline a physician for prescribing drugs 'for other than legal and legitimate therapeutic purposes' [11].

What is known about safety

FDA found no human pharmacokinetic or pharmacodynamic data for TB-500 by any route, no nonclinical toxicity studies, and no study of its immunogenicity; its stated concern is an immune reaction, possibly amplified by peptide aggregation and impurities [1].

TB-500 has no approved dose and no human dosing study [1]. An FDA-reviewed nomination described a proposed 3 mg/mL lyophilized powder for subcutaneous or intramuscular injection, but that proposal is not a recommended dose or treatment instruction [1].

Athletes

WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in section S2.3, prohibited at all times, and it appears on both the 2026 and 2027 Lists [6][12].

Is TB-500 legal in Ohio?
TB-500 is not FDA-approved and is not on FDA's list of bulk substances that can be used in compounding, so the standard bulk-substance pathway does not cover it [1][2]. An October 2026 HHS draft describes limited enforcement discretion for certain TB-500 acetate injections; it does not approve TB-500 [3][4].
Can an Ohio compounding pharmacy dispense TB-500?
Under the standard state-licensed pharmacy pathway, TB-500 meets none of FDA's listed conditions and appears in none of FDA's three interim categories [7][8][2]. The separate October 2026 HHS draft covers TB-500 acetate by subcutaneous or intramuscular injection, and applies only if conditions are met, such as a single active ingredient, a patient-specific prescription, and an FDA-registered manufacturer with a certificate of analysis [3][4].
Can an athlete use TB-500?
WADA's Prohibited List names thymosin-beta4 and its derivatives, giving TB-500 as an example, in section S2.3. It is prohibited at all times, in and out of competition, and appears on both the 2026 and 2027 Lists [6][12].
Show all 13 referencesHide references
Evidence overview for Is TB-500 Legal in Ohio? How to Access It Through a Licensed Provider